文献速递心外重症与机械循环支持

心脏移植后原发性移植物功能障碍的体外膜氧合治疗时机研究

Extracorporeal membrane oxygenation for primary graft dysfunction after heart transplant.
PubMed 文献 · J Thorac Cardiovasc Surg · 2019-02-28

该回顾性研究分析了2011至2017年间362例成人心脏移植受者,其中38例(10.5%)因严重原发性移植物功能障碍接受静脉-动脉体外膜氧合(VA-ECMO)治疗。结论认为及时VA-ECMO可促进心肌恢复并可能降低死亡率,且不增加并发症风险。

核心结论

  • 及时使用VA-ECMO治疗心脏移植后原发性移植物功能障碍可获得优异的心肌恢复,并可能降低死亡率而不增加并发症风险。

研究设计与样本

  • 按2015年实施及时VA-ECMO政策分为保守ECMO组(n=18)和及时ECMO组(n=20),比较临床结局。

主要发现

  • 两组ICU停留时间和主要并发症无差异。

关键数值与推荐

  • 严重原发性移植物功能障碍定义为需要VA-ECMO治疗。

临床怎么用

  • 对于心脏移植后严重原发性移植物功能障碍,及时启动VA-ECMO可能改善预后,不增加并发症。
  • 需注意本研究为回顾性单中心研究,及时ECMO的生存获益未达统计学显著性,应个体化决策。

局限性

  • 单中心回顾性研究,样本量小(38例接受ECMO)。
  • 组间基线特征存在差异(年龄、供体性别、供体射血分数、缺血时间等)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Venoarterial extracorporeal membrane oxygenation is a useful treatment for severe primary graft dysfunction after heart transplant. The ideal timing of initiation is unknown. METHODS: We retrospectively reviewed 362 adult heart transplant recipients at our center between January 2011 and December 2017. Thirty-eight patients (10.5%) experienced severe primary graft dysfunction treated with venoarterial extracorporeal membrane oxygenation. As our institution adopted a prompt venoarterial extracorporeal membrane oxygenation policy in 2015, patients were stratified into pre-2015 (conservative extracorporeal membrane oxygenation: n = 18) and post-2015 (prompt extracorporeal membrane oxygenation: n = 20) cohorts. Clinical outcomes were compared. RESULTS: Baseline characteristics were similar (conservative vs prompt) except for age (51.82 vs 59.96 years, P = .036), aspartate transaminase (32 vs 21.5 U/L, P = .038), male donor (44.4 vs 80%, P = .042), and donor ejection fraction (60 vs 65%, P = .047). Median ischemic time was significantly longer in the conservative extracorporeal membrane oxygenation cohort (210 vs 148 minutes, P = .005). Median time to initiation of extracorporeal membrane oxygenation was significantly shorter in the prompt extracorporeal membrane oxygenation cohort (7.26 vs 1.95 hours, P < .0001). There was no difference in intensive care unit stay or major complications. In-hospital mortality improved from 28% (conservative) to 5% (prompt, P = .083). Post-transplant survival at 1 year was 67% in the conservative extracorporeal membrane oxygenation cohort and 90% in the prompt extracorporeal membrane oxygenation cohort (P = .117). There was no difference in the Kaplan-Meier survival curves (P = .071), although Cox regression suggested, but certainly did not prove, a 74.6% lower risk of mortality in the prompt extracorporeal membrane oxygenation group (P = .094). CONCLUSIONS: Prompt venoarterial extracorporeal membrane oxygenation use for primary graft dysfunction after heart transplant results in excellent myocardial recovery and a possible decrease in mortality without increased risk of complications.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. DeRoo SC, Takayama H, Nemeth S, et al. Extracorporeal membrane oxygenation for primary graft dysfunction after heart transplant. J Thorac Cardiovasc Surg. 2019. PMID: 30948318. doi:10.1016/j.jtcvs.2019.02.065

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。